Lung Transplantation for Cystic Lung Diseases: Lymphangioleiomyomatosis, Histiocytosis X, and Sarcoidosis

 

 Buy Article Permissions and Reprints

ABSTRACT

Lung transplantation for respiratory failure due to lymphangioleiomyomatosis, histiocytosis X, and sarcoidosis is a therapeutic option in selected patients. These indications account for less than 6% of all lung transplant procedures, and experience is relatively scarce. Pulmonary function testing at evaluation usually shows an obstructive pattern in lymphangioleiomyomatosis, whereas histiocytosis presents with a mixed pattern, and sarcoidosis with a restrictive pattern. Lung diffusion capacity is similarly reduced, however, only histiocytosis and sarcoidosis are often associated with pulmonary hypertension. In all three diseases extrapulmonary manifestations, although of different kinds, are common and must be investigated before transplantation to avoid posttransplant diagnostic pitfalls. In all these diseases, single and bilateral transplantation show comparable results. Typical complications in lymphangioleiomyomatosis include intraoperative severe intrathoracic bleeding, posttransplant chylothorax, pneumothorax, and bleeding of angiomyolipomas. In histiocytosis, extrapulmonary manifestations in bones and pituitary gland may progress. These diseases typically recur in the allograft, leading to clinical symptoms in histiocytosis whereas recurrence in lymphangioleiomyomatosis and sarcoidosis is most often asymptomatic. Survival is similar to patients transplanted for other diseases.

REFERENCES

• 1 Hosenpud J D, Bennett L E, Keck B M, Boucek M M, Novick R J. The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000.  J Heart Lung Transplant . 2000;  19 909-931
  CrossrefPubMedGoogle Scholar
• 2 Maurer J R, Frost A E, Estenne M, Higenbottam T, Glanville A R. International guidelines for the selection of lung transplant candidates: The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society.  Transplantation . 1998;  66 951-956
  PubMedGoogle Scholar
• 3 Yeatman M, McNeil K, Smith J A. Lung transplantation in patients with systemic diseases: an eleven-year experience at Papworth Hospital.  J Heart Lung Transplant . 1996;  15 144-149
  PubMedGoogle Scholar
• 4 Johnson S. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms.  Thorax . 1999;  54 254-264
  PubMedGoogle Scholar
• 5 Rappaport D C, Weisbrod G L, Herman S J, Chamberlain D W. Pulmonary lymphangioleiomyomatosis: high-resolution CT findings in four cases.  Am J Roentgenol . 1989;  152 961-964
  PubMedGoogle Scholar
• 6 Costello L C, Hartman T E, Ryu J H. High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex.  Mayo Clin Proc . 2000;  75 591-594
  CrossrefPubMedGoogle Scholar
• 7 Ryu J H. Tuberous sclerosis complex and LAM. In: Moss J, ed. LAM and Other Diseases Characterized by Smooth Muscle Proliferation Vol 131. New York, NY: Marcel Dekker Inc 1999: 407-418
  Google Scholar
• 8 Smolarek T A, Wessner L L, McCormack F X, Mylet J C, Menon A G, Henske E P. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: Chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.  Am J Hum Genet . 1998;  62 810-815
  CrossrefPubMedGoogle Scholar
• 9 Sullivan E J, Beck G J, Stoller J K. The registry for individuals with lymphangioleiomyomatosis. In: Moss J, ed. LAM and other diseases characterized by smooth muscle proliferation New York, NY: Marcel Dekker Inc 1999: 99-110
  Google Scholar
• 10 NHLBI. Workshop summary: report of workshop on lymphangioleiomyomatosis.  Am J Respir Crit Care Med . 1999;  159 679-683
  PubMedGoogle Scholar
• 11 Boehler A, Speich R, Russi E W, Weder W. Lung transplantation for lymphangioleiomyomatosis.  N Engl J Med . 1996;  335 1275-1280
  CrossrefPubMedGoogle Scholar
• 12 Boehler A, Speich R, Russi E W, Weder W. International survey on lung transplantation in lymphangioleiomyomatosis. In: Moss J, ed. LAM and Other Diseases Characterized by Smooth Muscle Proliferation Vol 131. New York, NY: Marcel Dekker Inc 1999: 79-98
  Google Scholar
• 13 Trulock E P. Lung transplantation: special considerations and outcome in LAM. In: Moss J, ed. LAM and Other Diseases Characterized by Smooth Muscle Proliferation Vol 131. New York, NY: Marcel Dekker Inc 1999: 65-78
  Google Scholar
• 14 Silverstein E, Ellis K, Wolff M, Jaretzki A. Pulmonary lymphangioleiomyomatosis.  Am J Roentgenol . 1974;  120 12-50
  PubMedGoogle Scholar
• 15 Urban T, Lazor R, Lacronique J. Pulmonary lymphangioleiomyomatosis.  Medicine . 1999;  78 321-337
  CrossrefPubMedGoogle Scholar
• 16 Crausman R, Lynch D, Mortenson R. Quantitative CT predicts the severity of physiologic dysfunction in patients with lymphangioleiomyomatosis.  Chest . 1996;  109 131-137
  PubMedGoogle Scholar
• 17 Pigula F A, Griffith B P, Zenati M A, Dauber J H, Yousem S A, Keenan R J. Lung transplantation for respiratory failure resulting from systemic disease.  Ann Thorac Surg . 1997;  64 1630-1634
  CrossrefPubMedGoogle Scholar
• 18 Avila N A, Kelly J A, Chu S C, Dwyer A J, Moss J. Lymphangioleiomyomatosis: abdominopelvic CT and US findings.  Radiology . 2000;  216 147-153
  CrossrefPubMedGoogle Scholar
• 19 Maziak D E, Kesten S, Rappaport D C, Maurer J. Extrathoracic angiomyolipomas in lymphangioleiomyomatosis.  Eur Respir J . 1996;  9 402-405
  CrossrefPubMedGoogle Scholar
• 20 Oesterling J E, Fishman E K, Goldman S M, Marshall F F. The management of renal angiomyolipoma.  J Urol . 1986;  135 1121-1124
  PubMedGoogle Scholar
• 21 Blute M L, Malek R S, Segura J W. Angiomyolipoma: clinical metamorphosis and concepts for management.  J Urol . 1988;  139 20-24
  PubMedGoogle Scholar
• 22 Kennelly M J, Grossman H B, Cho K J. Outcome and analysis of 42 cases of renal angiomyolipoma.  J Urol . 1994;  152 1988-1991
  PubMedGoogle Scholar
• 23 Matsui K, Takeda K, Yu Z-X. Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy: an immunohistochemical study.  Am J Respir Crit Care Med . 2000;  161 1002-1009
  CrossrefPubMedGoogle Scholar
• 24 Logginidou H, Ao X, Russo I, Henske E P. Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis.  Chest . 2000;  117 25-30
  CrossrefPubMedGoogle Scholar
• 25 Nine J S, Yousem S A, Paradis I L, Keenan R, Griffith B P. Lymphangioleiomyomatosis: recurrence after lung transplantation.  J Heart Lung Transplant . 1994;  13 714-719
  PubMedGoogle Scholar
• 26 O'Brien J D, Lium J H, Parosa J F, Deyoung B R, Wick M R, Trulock E P. Lymphangiomyomatosis recurrence in the allograft after single-lung transplantation.  Am J Respir Crit Care Med . 1995;  151 2033-2036
  PubMedGoogle Scholar
• 27 Bittmann I, Dose T B, Müller C, Dienemann H, Vogelmeier C, Löhrs U. Lymphangioleiomyomatosis: recurrence after single lung transplantation.  Hum Pathol . 1997;  26 1420-1423
  PubMedGoogle Scholar
• 28 Tazi A, Soler P, Hance A J. Adult pulmonary Langerhans' cell histiocytosis.  Thorax . 2000;  55 405-416
  CrossrefPubMedGoogle Scholar
• 29 Vassallo R, Ryu J H, Colby T V, Hartman T, Limper A H. Pulmonary langerhans'-cell histiocytosis.  N Engl J Med . 2000;  342 1969-1978
  CrossrefPubMedGoogle Scholar
• 30 Delobbe A, Durieu J, Duhamel A, Wallaert B, and the groupe d'etude en pathologie interstitielle de la societe de pathologie thoracique du nord. Determinants of survival in pulmonary Langerhans'cell granulomatosis (histiocytosis X).  Eur Respir J . 1996;  9 2002-2006
  CrossrefPubMedGoogle Scholar
• 31 Schönfeld N, Frank W, Wenig S. Clinical and radiological features, lung function and therapeutic results in pulmonary histiocytosis X.  Respiration . 1993;  60 38-44
  PubMedGoogle Scholar
• 32 Fartoukh M, Humbert M, Capron F. Severe pulmonary hypertension in histiocytosis X.  Am J Respir Crit Care Med . 2000;  161 216-223
  CrossrefPubMedGoogle Scholar
• 33 Kaltsas G A, Powles T B, Evanson J. Hypothalamo-pituitary abnormalities in adult patients with Langerhans' cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment.  J Clin Endocrinol Metab . 2000;  85 1370-1376
  CrossrefPubMedGoogle Scholar
• 34 Gabbay E, Dark J H, Ashcroft T. Recurrence of Langerhans' cell granulomatosis following lung transplantation.  Thorax . 1998;  53 326-327
  CrossrefPubMedGoogle Scholar
• 35 Egan T M, Detterbeck F C, Keagy B A, Turpin S, Mill M R, Wilcox B R. Single lung transplantation for eosinophilic granulomatosis.  Southern Med J . 1992;  85 551-553
  PubMedGoogle Scholar
• 36 Etienne B, Bertocchi M, Gamondes J-P. Relapsing pulmonary Langerhans' cell histiocytosis after lung transplantation.  Am J Respir Crit Care Med . 1998;  157 288-291
  CrossrefPubMedGoogle Scholar
• 37 Habib S B, Congleton J, Carr D. Recurrence of recipient Langerhans' cell histiocytosis following bilateral lung transplantation.  Thorax . 1998;  53 323-325
  CrossrefPubMedGoogle Scholar
• 38 Egeler M R, Favara B E, van Meurs M, Laman J D, Claassen E. Differential in situ cytokine profiles of Langerhans'-like cells and T cells in Langerhans' cell histiocytosis: abundant expression of cytokines relevant to disease and treatment.  Blood . 1999;  94 4195-4201
  PubMedGoogle Scholar
• 39 Newman L S, Rose C S, Maier L A. Sarcoidosis.  N Engl J Med . 1997;  336 1224-1234
  CrossrefPubMedGoogle Scholar
• 40 Judson M A. An approach to the treatment of pulmonary sarcoidosis with corticosteroids.  Chest . 1999;  115 1158-1165
  CrossrefPubMedGoogle Scholar
• 41 Takada K, Ina Y, Noda M, Sato T, Yamamoto M, Morishita M. The clinical course and prognosis of patients with severe, moderate or mild sarcoidosis.  J Clin Epidemiol . 1993;  46 359-366
  CrossrefPubMedGoogle Scholar
• 42 Mana J, Salazar A, Manresa F. Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases.  Respiration . 1994;  61 219-225
  CrossrefPubMedGoogle Scholar
• 43 Du Bois M R. Corticosteroids in sarcoidosis: friend or foe?.  Eur Respir J . 1994;  7 1203-1209
  CrossrefPubMedGoogle Scholar
• 44 Lower E E, Baughman R P. The use of low dose methotrexate in refractory sarcoidosis.  Am J Med Sci . 1990;  299 153-157
  CrossrefPubMedGoogle Scholar
• 45 Perry A, Vuitch F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations.  Arch Pathol Lab Med . 1995;  119 167-172
  PubMedGoogle Scholar
• 46 Baughman R P, Winget D B, Bowen E H, Lower E E. Predicting respiratory failure in sarcoidosis patients.  Sarcoidosis Vasc Diffuse Lung Dis . 1997;  14 154-158
  PubMedGoogle Scholar
• 47 Arcasoy S M, Edelman J D, Wahl P M, Blumenthal N, Palevsky H I, Kotloff R M. Characteristics and outcome of patients with sarcoidosis listed for lung transplantation.  Am J Respir Crit Care Med . 2000;  161 A720
  PubMedGoogle Scholar
• 48 Judson M A. Lung transplantation for pulmonary sarcoidosis.  Eur Respir J . 1998;  11 738-744
  PubMedGoogle Scholar
• 49 Viskum K, Vestbo J. The prognosis of extrapulmonary sarcoidosis.  Sarcoidosis . 1994;  11 73-75
  PubMedGoogle Scholar
• 50 Walker S, Mikhail G, Banner N. Medium term results of lung transplantation for end stage pulmonary sarcoidosis.  Thorax . 1998;  53 281-284
  CrossrefPubMedGoogle Scholar
• 51 Martinez F J, Orens J B, Deeb M, Brunsting L A, Flint A, Lynch III P J. Recurrence of sarcoidosis following bilateral allogeneic lung transplantation.  Chest . 1994;  106 1597-1599
  CrossrefPubMedGoogle Scholar
• 52 Martel S, Carre P C, Carrera G, Pipy B, Leophonte P J, and the Toulouse Lung Transplantation Group. Tumour necrosis factor-alpha gene expression by alveolar macrophages in human lung allograft recipient with recurrence of sarcoidosis.  Eur Respir J . 1996;  9 1087-1089
  CrossrefPubMedGoogle Scholar
• 53 Johnson B A, Duncan S R, Ohori N P. Recurrence of sarcoidosis in pulmonary allograft recipients.  Am Rev Respir Dis . 1993;  148 1373-1377
  CrossrefPubMedGoogle Scholar
• 54 Kazerooni E A, Cascade P N. Sarcoidosis: recurrence of primary disease in transplanted lungs.  Radiology . 1994;  192 461-464
  CrossrefPubMedGoogle Scholar
• 55 Muller C, Briegel J, Haller M, and the Munich Lung Transplant Group. Sarcoidosis recurrence following lung transplantation.  Transplantation . 1996;  61 1117-1119
  PubMedGoogle Scholar
• 56 Björtuft O, Foerster A, Boe J, Geiran O. Single lung transplantation as treatment for end-stage pulmonary sarcoidosis: recurrence of sarcoidosis in two different lung allografts in one patient.  J Heart Lung Transplant . 1994;  13 24-29
  PubMedGoogle Scholar
• 57 Klemen H, Husain A N, Cagle P T, Garrity E R, Popper H H. Mycobacterial DNA in recurrent sarcoidosis in the transplanted lung: a PCR-based study on four cases.  Virchows Arch . 2000;  436 365-369
  CrossrefPubMedGoogle Scholar
• 58 Nunley D R, Hattler B, Keenan R J. Lung transplantation for end-stage pulmonary sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis . 1999;  16 93-100
  PubMedGoogle Scholar